Bristol-Myers Squibb (NYSE:BMY) Shares Sold by John G Ullman & Associates Inc.

John G Ullman & Associates Inc. cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 359,679 shares of the biopharmaceutical company’s stock after selling 7,818 shares during the period. Bristol-Myers Squibb accounts […]

Leave a Reply

Your email address will not be published.

Previous post Lavaca Capital LLC Has $634,000 Stock Position in NextEra Energy, Inc. (NYSE:NEE)
Next post John G Ullman & Associates Inc. Sells 100 Shares of Abbott Laboratories (NYSE:ABT)